Shelter-in-place policies reduce social contact and risks of interpersonal COVID-19 transmission. Though the economic consequences of these policies are substantial, local non-compliance creates public health risks and may cause regional spread. Understanding the drivers of what enhance or mitigate compliance is a first order public policy concern.

Clarifying these mechanisms provides actionable insights for policy makers and public health officials responding to the COVID-19 pandemic.

In our paper, we find a significant decline in population movement after the local shelter-in-place policies were enacted. Second, an increase in local income enhances compliance. Third, tariff-induced economic dislocation and higher Trump vote shares in 2016 reduce compliance. Finally, exposure to slanted media reduces compliance, consistent with the impact of information sources that downplayed the danger of COVID-19.

More on this topic

BFI Data Studio·May 14, 2024

Return to Office and the Tenure Distribution

Austin Wright, David Van Dijcke, and Florian Gunsilius
Return-to-office (RTO) mandates drive employees away from firms, with senior employees leaving at the highest rates, likely leading to significant human capital costs in terms of output, productivity, innovation, and competitiveness for the companies implementing strict RTO policies.
Topics: COVID-19, Employment & Wages
Research Briefs·Mar 7, 2024

What Drives Inflation? Lessons from Disaggregated Price Data

Elisa Rubbo
US inflation in the early phases of the COVID pandemic was entirely driven by disruptions in supply and demand across industries, whereas most of the subsequent increase in consumer prices is driven by aggregate demand.
Topics: COVID-19, Monetary Policy
Research Briefs·Feb 1, 2024

Quantifying the Social Value of a Universal COVID-19 Vaccine and Incentivizing Its Development

Rachel Glennerster, Thomas Kelly, Claire T. McMahon, and Christopher M. Snyder
A universal COVID-19 vaccine that is effective against existing and future variants could provide the United States population with $1.5–$2.6 trillion more in social value than variant-specific boosters. The social value of a universal vaccine eclipses the cost of incentivizing...
Topics: COVID-19